AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
+$3.36B
(-16%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
55
Reduced
75
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Supernus Pharmaceuticals
SUPN
$2.53B
| $140M | 2.15% | 5,092,000 +56,000 | +1% | +$1.54M |
|
|
2
PTC Therapeutics
PTCT
$3.92B
| $138M | 2.11% | 6,150,000 +2,914,000 | +90% | +$65.3M |
|
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $137M | 2.1% | 1,216,365 -433,635 | -26% | -$48.8M |
|
4
argenx
ARGX
$43.6B
| $98.3M | 1.51% | 200,000 | – | – |
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $82.3M | 1.26% | 3,324,000 +68,000 | +2% | +$1.68M |
|
6
Biogen
BIIB
$19.4B
| $71.1M | 1.09% | 276,788 +20,788 | +8% | +$5.34M |
|
7
Colgate-Palmolive
CL
$67.9B
| $68.4M | 1.05% | 962,000 +361,000 | +60% | +$25.7M |
|
8
Travere Therapeutics
TVTX
$1.56B
| $67.1M | 1.03% | 7,500,000 +50,000 | +0.7% | +$447K |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $66.4M | 1.02% | 3,456,000 +1,100,000 | +47% | +$21.1M |
|
10
Amazon
AMZN
$2.44T
| $66.3M | 1.02% | 521,369 -2,631 | -0.5% | -$334K |
|
11
Dentsply Sirona
XRAY
$2.85B
| $62.4M | 0.96% | 1,827,805 +27,805 | +2% | +$950K |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $61.7M | 0.95% | 74,998 -49,002 | -40% | -$40.3M |
|
13
Alphabet (Google) Class A
GOOGL
$2.57T
| $61.4M | 0.94% | 469,575 -78,425 | -14% | -$10.3M |
|
14
UnitedHealth
UNH
$281B
| $60.5M | 0.93% | 120,000 -30,000 | -20% | -$15.1M |
|
|
15
Incyte
INCY
$16.5B
| $59.8M | 0.92% | 1,036,000 -740,000 | -42% | -$42.7M |
|
|
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $59.4M | 0.91% | 1,364,098 -2,613,902 | -66% | -$114M |
|
|
DCPH
17
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $58.7M | 0.9% | 4,612,000 +52,000 | +1% | +$661K |
|
18
Freshpet
FRPT
$2.72B
| $53.7M | 0.82% | 814,729 -235,271 | -22% | -$15.5M |
|
19
Alkermes
ALKS
$4.78B
| $53.1M | 0.81% | 1,896,775 -103,225 | -5% | -$2.89M |
|
20
Biohaven
BHVN
$1.63B
| $53M | 0.81% | 2,036,000 +236,000 | +13% | +$6.14M |
|
21
Medtronic
MDT
$119B
| $52.6M | 0.81% | 671,407 -84,593 | -11% | -$6.63M |
|
22
Exact Sciences
EXAS
$8.98B
| $48.5M | 0.74% | 711,520 +239,520 | +51% | +$16.3M |
|
23
Aurinia Pharmaceuticals
AUPH
$1.58B
| $47M | 0.72% | 6,048,000 +1,356,000 | +29% | +$10.5M |
|
24
Post Holdings
POST
$6.15B
| $45.8M | 0.7% | 533,634 +25,224 | +5% | +$2.16M |
|
25
Keurig Dr Pepper
KDP
$39.5B
| $45.5M | 0.7% | 1,442,332 +95,332 | +7% | +$3.01M |
|